Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Biosimilar Firms Main Beneficiaries Of Korea R&D Cost Accounting Changes?
Sep 25 2018
•
By
Jung Won Shin
New Korean Guidelines For R&D Cost Related Accounting • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from South Korea
More from Focus On Asia